DXCM

Q: What is the price of DexCom (DXCM) today?

The price of DexCom (DXCM) today is R$ 414,09, with a variation of 5.37% compared to the last year. The price of DexCom (DXCM) started the year trading around R$ 423,07 and today it is at R$ 414,09. Follow the real-time price chart, the historical price of DexCom (DXCM), and stock data from Ibovespa and international markets.

Q: When does DexCom (DXCM) pay dividends?

DexCom (DXCM) did not distribute dividends in the last year.

Q: DexCom (DXCM) is it worth it?

Currently, DexCom (DXCM) is priced at R$ 414,09, with a P/E of 56,42%, representing a deviation of 85,35% from its historical average P/E. In the last year, the stock showed a variation of 5.37% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 5,37%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of DexCom (DXCM)?

Investing in shares of DexCom (DXCM) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of DexCom (DXCM) yield today?

The yield of DexCom (DXCM) was -14,46% in the last month, 5,37% in the last year and -27,32% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of DexCom (DXCM) today, the total investment would be based on the current price of R$ 414,09.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 43.632,96In 5 years: R$ 30.096,26In 10 years: 133.930,03It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

DexCom Inc.

Price

US$ 76,12

variation (12m)

5,37%

p/l

56,42

p/vp

12,53

DIVIDEND YIELD

0,00%

quote DXCM

BVMF

DXCM

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of DXCM

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-14,46%

3 months

-12,49%

1 year

5,37%

2 years

-23,34%

5 years

-27,32%

10 years

223,43%

real profitability

profitability minus inflation.

1 month

-14,46%

3 months

-12,93%

1 year

0,12%

2 years

-30,12%

5 years

-46,89%

10 years

91,74%

Indicators DXCM

check out the fundamentals of DexCom shares

P/L

56,42

Sector: -1,52 Industry: -3,80

P/SALES (PSR)

7,50

Sector: 1,99 Industry: 2,90

P/VP

12,53

Sector: 2,16 Industry: 1,76

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

7,80%

Sector: -26,53% Industry: -56,94%

ROE

22,21%

Sector: -31,21% Industry: -45,34%

ROIC

18,21%

Sector: -404,40% Industry: -420,46%

Net Margin

13,29%

Sector: -26,56% Industry: -32,35%

GROSS MARGIN

58,77%

Sector: 44,49% Industry: 44,86%

OPERATING MARGIN

15,98%

Sector: -23,10% Industry: -30,21%

P/EBITDA

37,59

Sector: 0,07 Industry: -2,60

P/EBIT

43,42

Sector: -1,37 Industry: -3,22

P/ASSETS

4,40

Sector: 1,23 Industry: 1,32

VPA

6,56

Sector: 3,66 Industry: 1,68

LPA

1,46

Sector: -0,80 Industry: -1,22

EQUITY / ASSETS

0,35

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

17,42%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

2,97%

Sector: - Industry: -

FAIR PRICE OF DexCom ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 76,12

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-80,71%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

DXCM indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
LLY	45,25	34,03	75,21%	0,81%	US$ 624,41 B	25,91%
ISRG	65,56	9,52	14,52%	0,00%	US$ 170,94 B	28,51%
TMO	28,71	3,73	13,01%	0,33%	US$ 189,00 B	15,24%
MDT	25,50	0,00	0,00%	3,03%	US$ 118,85 B	13,63%
SNY	11,17	1,55	13,90%	4,31%	US$ 125,86 B	14,83%
CVS	19,92	1,16	5,84%	3,73%	US$ 90,27 B	1,17%
GSK	17,94	4,15	23,12%	4,04%	US$ 80,77 B	10,87%
ABT	15,66	4,31	27,50%	1,81%	US$ 218,97 B	32,43%
NVS	18,12	5,88	32,47%	3,05%	US$ 247,36 B	24,74%
TMDX	56,86	12,81	22,53%	0,00%	US$ 4,07 B	13,49%
HCA	16,35	-78,84	-482,31%	0,68%	US$ 97,60 B	8,21%
BSX	62,73	6,94	11,06%	0,00%	US$ 157,13 B	13,54%
INMD	5,22	1,48	28,44%	0,00%	US$ 933,03 M	44,50%
DHR	44,49	2,90	6,52%	0,56%	US$ 151,86 B	14,21%
IDXX	52,40	35,40	67,57%	0,00%	US$ 51,64 B	24,41%
FMS	20,59	0,91	4,42%	3,07%	US$ 15,03 B	3,41%
HUM	23,00	1,98	8,61%	1,18%	US$ 36,24 B	1,28%
PHG	127,59	2,23	1,75%	3,13%	US$ 26,81 B	1,07%
RMD	30,62	7,19	23,47%	0,72%	US$ 42,88 B	27,22%

comparison of DXCM with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history DXCM dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY DexCom

DexCom Inc.

Average user rating I10

4.0 (12 people)

Estados Unidos

26 years

Foundation: 1999

2005

Year of debut on the stock exchange - 20 years

6.400

Employees

The Company DexCom Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 32,25 Billions, having a net worth of $ 2,57 Billions.

With a total of 6.400 employees, the company is listed in the sector of Saúde and categorized in industry of Materiais e Equipamentos Médicos.

In the last 12 months the Company had a revenue of $ 4,30 Billions, which generated a profit in the amount of $ 571,50 Milhões.

As for its main indicators, the Company has a P/E ratio of 56,42, a P/B ratio of 12,53 and in the last 12 months the Company did not pay dividends.

The Company is traded in Brazil through the BDR D1EX34, or can be purchased on abroad through the ticker DXCM.

Market value

US$ 32,25 Billions

Net worth

US$ 2,57 Billions

US$ 2.573.100.000,00

Assets

US$ 7,33 Billions

US$ 7.327.000.000,00

Total Number of Shares

392,00 Milhões

392.000.000

Average Daily Trading Volume

US$ 3,66 Milhões

US$ 3.661.970,00

Sector

Saúde

Industry

Materiais e Equipamentos Médicos

DXCM

DXCM revenue and profits

DXCM results

DRAG THE FRAME TO SEE MORE DATA

DXCM cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12 M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12 M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12 M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12 M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12 M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12 M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12 M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

Common Questions

What is the price of DexCom (DXCM) today?

The price of DexCom (DXCM) today is R$ 414,09, with a variation of 5.37% compared to the last year. The price of DexCom (DXCM) started the year trading around R$ 423,07 and today it is at R$ 414,09. Follow the real-time price chart, the historical price of DexCom (DXCM), and stock data from Ibovespa and international markets.

When does DexCom (DXCM) pay dividends?

DexCom (DXCM) did not distribute dividends in the last year.

DexCom (DXCM) is it worth it?

Currently, DexCom (DXCM) is priced at R$ 414,09, with a P/E of 56,42%, representing a deviation of 85,35% from its historical average P/E. In the last year, the stock showed a variation of 5.37% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 5,37%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of DexCom (DXCM)?

Investing in shares of DexCom (DXCM) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of DexCom (DXCM) yield today?

The yield of DexCom (DXCM) was -14,46% in the last month, 5,37% in the last year and -27,32% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of DexCom (DXCM) today, the total investment would be based on the current price of R$ 414,09.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 43.632,96
In 5 years: R$ 30.096,26
In 10 years: 133.930,03

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

DXCM

DexCom Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of DXCM

check out the fundamentals of DexCom shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY DexCom

DexCom Inc.

Estados Unidos

26 years

2005

6.400

PROFIT X PRICE DXCM

DXCM results

DXCM cash flow

evolution of assets - DXCM

DXCM balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80